Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 16, 2000

View Archived Issues

ML Laboratories Acquires Cobra For Stock Worth #8M

C. Jejuni Sequenced, Shows Significant Phase Variation

EMEA Preparing Guidelines To Regulate Gene Therapy

Lion Extends Bioinformatics Platform With Tripos Alliance

Xenova, University In Pact To Develop Telomerase Inhibitors

CSL Agrees To Make Vaccine Against Biological Weapons

SignalGene Offers Services In Pharmacogenomics Area

Molecular Biologists In EU Join In Debate Over GMOs

Corixa, Genset Collaborate In Microbial Genomics Area

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.